PHK-helicase inhibitor (Aviron Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePHK-helicase inhibitor (Aviron Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA helicases inhibitors
TargetsRNA helicases
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAviron Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAviron Pharma
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A